Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 732-735

  Hecht, Stephen S ^a,b   Carmella, Steven G ^a   Stepanov, Irina ^a   Jensen, Joni ^a   Anderson, Amanda ^a   Hatsukami, Dorothy K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; GLUCURONIDE;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; SALIVA ANALYSIS; SMOKELESS TOBACCO; SMOKING; URINALYSIS;

ADULT; GLUCURONATES; HUMANS; MALE; NITROSAMINES; TOBACCO, SMOKELESS;

EID: 41549145833     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2843     Document Type: Article

References (21)

1. IARC. Smokeless tobacco and tobacco-specific nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 89. Lyon (France): IARC; 2007. p. 553.
2. IARC. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 83. Lyon (France): IARC; 2004. p. 53-119.
3. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988;9:875-84.
4. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
5. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
6. Carmella SG, Akerkar S, Hecht SS. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res 1993;53:721-4.
7. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
8. Hecht SS, Carmella SG, Le K, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev 2006;15:988-92.
9. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev 2005;14:2963-8.
10. Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS. Changing smokeless tobacco products: new tobacco delivery systems. Am J Prev Med 2006;33:5368-78.
11. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 2006;8:600-22.
12. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006;8:309-13.
13. Carmella SG, Han S, Fristad A, Yang Y, Hecht SS. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev 2003;12:1257-61.
14. Carmella SG, Akerkar S, Richie JP, Jr., Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4:635-42.
15. Hecht SS, Carmella SG, Ye M, et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone after cessation of smokeless tobacco use. Cancer Res 2002;62:129-34.
16. Hecht SS, Carmella SG, Murphy SE, et al. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007;16:1567-72.
17. Hecht SS, Carmella SG, Edmonds A, et al. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob Control. In press 2008.
18. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988;48:6912-7.
19. Hecht SS, Trushin N, Reid-Quinn CA, et al. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 1993;14:229-36.
20. Morse MA, Eklind KI, Toussaint M, Amin SG, Chung FL. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis 1990;11:1819-23.
21. Carmella SG, Borukhova A, Akerkar SA, Hecht SS. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone, a tobacco-specific lung carcinogen. Cancer Epidemiol Biomarkers Prev 1997;6:113-20.